跳至主要内容
临床试验/NCT00725218
NCT00725218已完成4 期

Phase IV Study of Flurbiprofen Axetil for Uterine Contraction Pain After Abortion

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
97
试验地点
1
主要终点
VAS pain scorings

研究概览

简要总结

Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress the uterine contraction pain after abortion effectively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA status I-II
  • Performing abortion operation (medical- or drug-induced
  • Requiring painless abortion

排除标准

  • < 19yrs, and >= 45yrs
  • History of central active drugs administration
  • Drug abuse
  • Hypertension
  • Any other chronic diseases
  • Allergy to the study drugs
  • Habit of over-volume alcohol drinking
  • Records of history of centrally active drug use and psychiatry
  • Any organic disorders

研究组 & 干预措施

1

Placebo Comparator

Saline 5 ml injection 10 min prior to propofol administration.

干预措施: Saline (Drug)

2

Experimental

Flurbiprofen Axetil 50 mg in 5 ml injection 10min prior to propofol administration.

干预措施: Flurbiprofen Axetil (Drug)

结局指标

主要结局

VAS pain scorings

时间窗: At the end of the operation, 0,5,15,30,60min after operation

次要结局

  • Anesthetic consumptions(At the end of the operation)
  • Overall VAS satisfaction scorings with analgesia(At the end of the study)
  • Side effects(During the whole period of the study)
  • Volume of bleeding(At the end of the study)

研究者

发起方
Nanjing Medical University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验